QIAGEN CLC Genomics
Disrupting Healthcare Using Deep Data, Remote Monitoring and AI
19 views
Today’s healthcare system largely reacts to illness rather than preventing it. Researchers at Stanford University School of Medicine are pioneering a new approach: using big data, multi-omics technologies, and continuous remote monitoring to understand health while people are still well and detect disease at its earliest, pre-symptomatic stages. By combining genomics, immunomics, transcriptomics, proteomics, metabolomics, microbiomics, wearable devices and microsampling, scientists can track health and biological change in unprecedented detail.
In this webinar, Michael Snyder will present findings from a long-term study of 200 individuals followed for up to 15 years, revealing major insights into cardiovascular disease, cancer, metabolic health, and infectious disease. Key discoveries include distinct, measurable aging patterns, how wearable devices can be used for early detection of infectious diseases, such as COVID-19, and how microsampling can be used for monitoring and improving lifestyle.
Related videos
QIAGEN CLC Genomics
QIAGEN CLC Genomics Workbench 20 – scalable desktop software for NGS data analysis
In this webinar, Leif Schauser, Ph.D., Director Product Management Genome...
QIAGEN OmicSoft and Biomedical Knowledge Base
Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...
High-quality biomedical relationships knowledge is the cornerstone of modern...
QIAGEN CLC Genomics
16S/18S/ITS sequencing analysis using CLC Genomics Workbench
QIAGEN CLC Microbial Genomics Module provides tools and workflows for a broad...
QIAGEN CLC Genomics
De novo assembly, BLAST and genome finishing using QIAGEN CLC Genomics Workbench
This webinar will introduce users to the tools available for short reads...